Blood cancer Clinical Trials in Tampa, FL

As of September 2026, 63 paid clinical trials are recruiting for Blood cancer in Tampa, Florida. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: September 1, 2026.

Filter results

State

City

Facility

Recruitment status

Phase

Study type

Intervention

Condition

Sex

Age

Healthy volunteers only

64 clinical trials for Blood cancer

·Clear filters·

Email me when a new blood cancer trial opens in Tampa, FL.

Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)

for Acute Myeloid Leukemia

Drug: Venetoclax

Sites in Tampa, Orlando +43 more locations

Sponsor: PedAL BCU, LLC

Sex: All·Age: 29 Days - 21

Code: NCT05183035·Phase 3·Recruiting·Listed Jan 2022

Apply to this trial

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

for Acute Lymphoblastic Leukemia

Sites in Tampa, St. Petersburg +154 more locations

Sponsor: PedAL BCU, LLC

Sex: All·Age: Up to 22

Code: NCT04726241·Phase 1, Phase 2·Recruiting·Listed Jan 2021

Apply to this trial

Testing Teclistamab (TECVAYLI) in Combination With Iberdomide for Relapsed or Refractory Multiple Myeloma

for Recurrent Multiple Myeloma

Drug: Teclistamab

Sites in Tampa, Jacksonville +12 more locations

Sponsor: National Cancer Institute (NCI)

Sex: All·Age: 18+

Code: NCT06465316·Phase 1·Recruiting·Listed Jun 2024

Apply to this trial

Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell Transplantation

for Multiple Myeloma

Drug: Teclistamab

Sites in Tampa, Orlando +39 more locations

Sponsor: European Myeloma Network B.V.

Sex: All·Age: 18+

Code: NCT05243797·Phase 3·Recruiting·Listed Feb 2022

Apply to this trial

A Phase Ib Study of Rezatapopt in Combination With Azacitidine in Patients With TP53Y220C Mutant Myeloid Malignancies (Acute Myeloid Leukemia or Myelodysplastic Syndrome)

for Myelodysplastic Syndrome

Drug: rezatapopt

Sites in Tampa +1 more location

Sponsor: M.D. Anderson Cancer Center

Sex: All·Age: 18+

Code: NCT06616636·Phase 1·Recruiting·Listed Sep 2024

Apply to this trial

Biomarkers to Predict Cancer Therapy-related Cardiotoxicity

for Hematopoietic and Lymphatic System Neoplasm

Sites in Tampa, Jacksonville +1 more location

Sponsor: Mayo Clinic

Sex: All·Age: 18+

Code: NCT06353191·Recruiting·Listed Apr 2024

Apply to this trial

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

for Breast Carcinoma

Sites in Tampa, St. Petersburg +462 more locations

Sponsor: Wake Forest University Health Sciences

Sex: All·Age: 18+

Code: NCT06418204·Recruiting·Listed May 2024

Apply to this trial

IVIG for Infection Prevention After CAR-T-Cell Therapy

for Hematologic Malignancies

Sites in Tampa, Miami +5 more locations

Sponsor: Fred Hutchinson Cancer Center

Sex: All·Age: 18+

Code: NCT05952804·Phase 2·Recruiting·Listed Jul 2023

Apply to this trial

A Culturally-Tailored Mobile Health and Social Media Physical Activity Intervention for Improving Physical Activity in Hispanic or Latino/Latina Adolescent and Young Adult Childhood Cancer Survivors, Walking Juntos Study

for Hematopoietic and Lymphatic System Neoplasm

Sites in Tampa, St. Petersburg +74 more locations

Sponsor: Children's Oncology Group

Sex: All·Age: 15 - 20

Code: NCT06410209·Phase 2·Recruiting·Listed May 2024

Apply to this trial

Tafasitamab and Lenalidomide as First Salvage Therapy for Residual Large B Cell Lym

for Large B-cell Lymphoma

Drug: Tafasitamab

1 location in Tampa

Sponsor: H. Lee Moffitt Cancer Center and Research Institute

Sex: All·Age: 18+

Code: NCT06760156·Phase 2·Recruiting·Listed Jan 2025

Apply to this trial

Phase 2 Open Label Randomized Study of Pirtobrutinib and Brexucabtagene Autoleucel in R/R MCL

for Mantle Cell Lymphoma

Sites in Tampa, Miami +1 more location

Sponsor: H. Lee Moffitt Cancer Center and Research Institute

Sex: All·Age: 18+

Code: NCT06553872·Phase 2·Recruiting·Listed Aug 2024

Apply to this trial

Single-Arm Comprehensive Ablative Bridging Irradiation I Prior to CD19 CAR-T In High-Risk R/R LBCL

for Large B-cell Lymphoma

1 location in Tampa

Sponsor: H. Lee Moffitt Cancer Center and Research Institute

Sex: All·Age: 18+

Code: NCT06104592·Phase 2·Recruiting·Listed Oct 2023

Apply to this trial

Study of KTE-X19 in Minimal Residual Disease (MRD) Positive B-Cell Acute Lymphoblastic Leukemia (B-ALL)

for B-Cell Lymphoblastic Leukemia

1 location in Tampa

Sponsor: H. Lee Moffitt Cancer Center and Research Institute

Sex: All·Age: 18+

Code: NCT06144606·Phase 2·Recruiting·Listed Nov 2023

Apply to this trial

Graft Versus Host Disease-Reduction Strategies for Donor Blood Stem Cell Transplant Patients With Acute Leukemia or Myelodysplastic Syndrome (MDS)

for Acute Leukemia

Sites in Tampa +2 more locations

Sponsor: Fred Hutchinson Cancer Center

Sex: All·Age: 1 - 60

Code: NCT03970096·Phase 2·Recruiting·Listed May 2019

Apply to this trial

CalPeg for Newly Diagnosed Acute Lymphoblastic Leukemia (ALL)

for Acute Lymphoblastic Leukemia

1 location in Tampa

Sponsor: H. Lee Moffitt Cancer Center and Research Institute

Sex: All·Age: 18 - 50

Code: NCT05581030·Phase 1·Recruiting·Listed Oct 2022

Apply to this trial

Discontinuation of Hypomethylating Agent and Venetoclax in Patients With AML MRD

for Acute Myeloid Leukemia

Drug: Venetoclax

1 location in Tampa

Sponsor: H. Lee Moffitt Cancer Center and Research Institute

Sex: All·Age: 18+

Code: NCT06511882·Phase 2·Recruiting·Listed Jul 2024

Apply to this trial

CPX-351 in Combination With Gemtuzumab Ozogamicin in Newly Diagnosed AML

for Acute Myeloid Leukemia

1 location in Tampa

Sponsor: H. Lee Moffitt Cancer Center and Research Institute

Sex: All·Age: 18 - 70

Code: NCT05558124·Phase 1·Recruiting·Listed Sep 2022

Apply to this trial

Rituximab and Zanubrutinib in Patients With Indolent B-cell Lymphomas

for Follicular Lymphoma

Drug: Rituximab

1 location in Tampa

Sponsor: H. Lee Moffitt Cancer Center and Research Institute

Sex: All·Age: 18+

Code: NCT06350318·Phase 2·Recruiting·Listed Apr 2024

Apply to this trial

BMT-CARE: Psychosocial Intervention for Transplant Caregivers

for Bone Marrow Transplant Complications

Sites in Tampa +2 more locations

Sponsor: Massachusetts General Hospital

Sex: All·Age: 18+

Code: NCT06472089·Recruiting·Listed Jun 2024

Apply to this trial

Itacitinib Pre-modulation in DLBCL Receiving CAR T Cell Therapy

for Diffuse Large B Cell Lymphoma

Drug: Itacitinib

1 location in Tampa

Sponsor: H. Lee Moffitt Cancer Center and Research Institute

Sex: All·Age: 18+

Code: NCT05757219·Phase 2·Recruiting·Listed Mar 2023

Apply to this trial

A Study to Compare Elritercept to Placebo in Adults With Myelofibrosis and Anemia Who Are Taking Ruxolitinib

for Myelofibrosis

Drug: Ruxolitinib

Sites in Tampa, Orlando +28 more locations

Sponsor: Takeda

Sex: All·Age: 18+

Code: NCT07623161·Phase 3·Recruiting·Listed Jun 2026

Apply to this trial

A Study to Assess Adverse Events and Change in Disease Activity When Intravenous (IV) Pivekimab Sunirine is Given in Combination With Oral Venetoclax and IV or Subcutaneous Azacitidine in Adult Participants With Acute Myeloid Leukemia (AML)

for Acute Myeloid Leukemia

Drug: Venetoclax

Sites in Tampa +2 more locations

Sponsor: AbbVie

Sex: All·Age: 18+

Code: NCT07581002·Phase 2, Phase 3·Recruiting·Listed May 2026

Apply to this trial

A Phase I, Open-label, Multicenter Study to Evaluate the Safety, Tolerability, Cellular Kinetics, Immunogenicity, Pharmacodynamics, and Preliminary Efficacy of AZD0120 in Participants With Multiple Myeloma (DURGA-2)

for Multiple Myeloma

Sites in Tampa +9 more locations

Sponsor: AstraZeneca

Sex: All·Age: 18+

Code: NCT07073547·Phase 1·Recruiting·Listed Jul 2025

Apply to this trial

Conditions in Blood cancer (Tampa, FL)

Acute myeloid leukemia (AML)· 18 Myelodysplastic syndromes (MDS)· 17 Multiple myeloma· 10 Non-Hodgkin lymphoma· 8 Hematologic malignancy· 8 Leukemia (other)· 7 Acute lymphoblastic leukemia· 6 Diffuse large B-cell lymphoma (DLBCL)· 6 Chronic lymphocytic leukemia (CLL)· 5 Follicular lymphoma· 5 Mantle cell lymphoma· 5 Myelofibrosis· 4 Marginal zone lymphoma· 4 Myeloproliferative neoplasm· 3 Small lymphocytic lymphoma· 3 Chronic myelomonocytic leukemia· 1